Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation. Issue 1 (1st April 2015)

• Record Type: Journal Article
• Authors: Huang, Ching-Ting; Chang, Ming-Cheng; Chen, Yu-Li; Chen, Tsung-Ching; Chen, Chi-An; Cheng, Wen-Fang
• Is Part Of: Cancer letters. Volume 359:Issue 1(2015)
• Page Start: 117
• Page End: 126
• Publication Date: 2015-04-01
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Electronic journals; 616.994
• DOI: 10.1016/j.canlet.2015.01.007
• Languages: English
• ISSNs: 0304-3835

Abstract

<abstract abstract-type="author-highlights" id="ab0010"> <title id="st0010">Highlights</title> <sec> <p id="sp0010"> <list id="ulist0010"> <list-item id="u0010"> <label></label> <p id="p0010">IGFs can inhibit DC-mediated anti-tumor immunity and the IGF1R inhibitor could restore it.</p> </list-item> <list-item id="u0015"> <label></label> <p id="p0015">Blockade of IGFs could be a potential strategy for cancer immunotherapy.</p> </list-item> </list> </p> </sec> </abstract>